Skip to main content

Christopher McGinnis

Equibles does not estimate personal net worth.

Get an email with a short summary when ACCO BRANDS Corp publishes a filing, an earnings call transcript or a press release.

Get ACCO alerts

About Christopher McGinnis

Christopher McGinnis is recorded as Head of Investor Relations at ACCO BRANDS Corp (ACCO) and CFO at GoodRx Holdings, Inc. (GDRX). The newest filing on record that lists Christopher McGinnis as CFO at GoodRx Holdings, Inc. (GDRX) is dated April 29, 2026. The proxy statement of GoodRx Holdings, Inc. reports total compensation of $8,698,916 for Christopher McGinnis in fiscal 2025, including a base salary of $454,808. Christopher McGinnis has spoken on 6 earnings calls across 2 companies, most recently for GoodRx Holdings, Inc. on May 7, 2026. Those appearances were for GoodRx Holdings, Inc. (GDRX) and ACCO BRANDS Corp (ACCO). GoodRx Holdings, Inc. is classified in the Health Information Services industry within the Healthcare sector. ACCO BRANDS Corp is classified in the Business Equipment & Supplies industry within the Industrials sector. Other leadership on record at GoodRx Holdings, Inc. includes Scott Wagner (CEO, Chairman and Board Member), Wendy Barnes (CEO and Board Member), Trevor Bezdek (Chairman) and 7 others.

Christopher McGinnis on recent calls

“For the first quarter, we delivered revenue of $194 million and adjusted EBITDA of $58.3 million, representing an adjusted EBITDA margin of 30%.”
CFO, GoodRx Holdings, Inc. Q1 FY2026 Earnings Call ·
“Good morning and welcome to the ACCO Brands conference call to review our first quarter 2026 results speaking on the call today is tom tedward president chief executive officer of accobrands and deb o'connor executive vice president and chief financial officer slides of the company of this call have been posted to the…”
Head of Investor Relations, ACCO BRANDS Corp Q1 FY2026 Earnings Call ·
“For the third quarter, total revenue was $196 million, up approximately $1 million versus the prior year.”
CFO, GoodRx Holdings, Inc. Q3 FY2025 Earnings Call ·
“For the second quarter, total revenue was $203.1 million, up 1% versus the prior year. This is in line with our expectations when excluding the impact of Rite Aid, which, as a reminder, the guidance provided in May excluded the impact from Rite Aid.”
CFO, GoodRx Holdings, Inc. Q2 FY2025 Earnings Call ·
“Good morning, and welcome to the ACCO Brands’ Fourth Quarter and Full Year 2023 Conference Call. This is Chris McGinnis, Senior Director of Investor Relations. Speaking on the call today is Tom Tedford, President and Chief Executive Officer of ACCO Brands Corporation.”
Head of Investor Relations, ACCO BRANDS Corp Q4 FY2023 Earnings Call ·

Affiliation history

Company network

Leadership on record at GoodRx Holdings, Inc.

Leadership on record at ACCO BRANDS Corp

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 GoodRx Holdings, Inc. (GDRX) $454,808 $8,698,916

Recent activity